FGF7 and ocular melanoma: The MASCC/ISOO guideline [5] recommends in specific situations for OM: recombinant human keratinocyte growth factor (KGF-1/palifermin), photobiomodulation (previously termed ‘low-level laser therapy’), patient-controlled analgesia with morphine and oral cryotherapy.